Company profile

Baiying Bio company profile

Baiying Bio offers economic recombinant protein and antibody reagents and is a CRO vendor for life science researchers and biopharma companies. They provide services including HTP recombinant antibody and VHH production, bispecific antibody production, antibody humanization, VHH library generation, hybridoma sequencing, protein expression in mammalian cells, large-scale antibody production, and more. They delivered tens of thousands of recombinant antibodies to customers.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00251-00500 employees
Revenue range
$100K+
Founded
2012-01-01

Headquarters

Headquarters
Beijing, China
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$72.6M
Last funding
Series B / $72.6M / 2022-08-31
Last equity funding
Series B / $72.6M
Investors
12
Lead investors
2

Founders and investors

Lead investors

BW VenturesRui Mengxi Capital

Investors

Binfu CapitalCo-Stone Venture CapitalGaorong CapitalJoy CapitalLYFE Capital

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.